New Delhi, Jan 19: Even as the healthcare sector witnessed squeezing of revenues due to the Covid-19 pandemic, its long-term outlook remains stable on the back of swift rebound in occupancy as well as structural factors, ICRA said on Monday.
The rating agency expects the occupancy of companies in the sector to bounce back substantially to 60 per cent in FY22, from the estimated occupancy of 52 per cent in FY21, and the revenue growth to be at 20 per cent in FY22, against an estimated contraction of 19 per cent in FY21, aided by a lower base as well.
There has been significant sequential improvement in occupancy every month after the sharp fall in April and the pent-up demand is also likely to support the performance, as elective procedures cannot be delayed indefinitely by domestic as well as international patients, the report noted.
Due to the high operating leverage, the EBITDA margin is likely to rise to 13 per cent in FY22, against an estimated EBITDA margin of 9 per cent in FY21. The capital expansion was already slowing down, even pre-Covid, and is likely to remain modest in FY22 as the players have adequate capacity to grow over the medium term and the near-term focus is on better utilisation of the existing facilities rather than expansion of the network.
Consequently, the capex as well as startup costs of new hospitals are likely to be much lower going forward, which will also aid profitability. The net debt is expected to stay largely range-bound, but the debt protection metrics is likely to improve significantly due to a sharp rise in accruals, ICRA said.
According to Kapil Banga, Assistant Vice President, ICRA: “The credit risk profile of entities in the sector had been on improving the trajectory over the last two years and notwithstanding the near-term disruption due to the pandemic, as well as given the essential nature of the services, ICRA believes the sector will resume on its growth trajectory in FY22. The risks to the recovery could be in the form of additional regulatory measures, protracted restrictions on international travel and jump in Covid-19 cases”.